In people with untreated MS, CD16+ monocytes were reported to have higher expression of a number of activating receptors, including the FcγRI (CD64), and secrete less IL-10 upon ex vivo activation compared with classical monocytes36. The gene discussed is FCGR1A; the disease is myeloid sarcoma.